Company news

AstraZeneca PLC news in 2025

AstraZeneca PLC's news releases, calls and decks from 2025, newest first.

View company

Imfinzi approved in EU for limited-stage SCLC

March 17, 2025

AstraZeneca to acquire EsoBiotec

March 17, 2025

Notice of AGM

March 7, 2025

Imfinzi improved EFS in early-stage gastric cancer

March 7, 2025

Imfinzi recommended for EU approval for AEGEAN

March 3, 2025

Enhertu recommended in EU in post-ET breast cancer

February 28, 2025

Camizestrant improved PFS in 1L HR+ breast cancer

February 26, 2025

Directorate Change

February 18, 2025

Imfinzi recommended for EU approval for LS-SCLC

February 3, 2025

Enhertu approved in US for breast cancer post ET

January 28, 2025

Dato-DXd approved in US for HR+ breast cancer

January 20, 2025

Calquence combination approved in US for 1L MCL

January 17, 2025

← Newer news releases

Calls in 2025

Decks in 2025